Outsourced Pharma App Notes & Case Studies

1. Enhancing Viral Clearance Prediction And Process Optimization 7/11/2025

   MockV technology enables early, in-house viral clearance assessment, helping biopharma developers improve process robustness, reduce costs, and enhance safety before GMP manufacturing begins.

2. Improving Efficiency In Contamination Identification 7/11/2025

   Discover how rapid microbial identification using MALDI-TOF improves contamination response, shortens investigation timelines, and enhances efficiency in biopharmaceutical manufacturing.

3. Elevating Downstream Process Development With Real-Time Data Monitoring 7/11/2025

   Learn how real-time monitoring with PAT enhances process control, shortens development timelines, and supports the shift toward continuous manufacturing in biopharmaceutical production.

4. Leveraging Surface Plasmon Resonance For Characterizing Ternary Complexes 6/13/2025

   Uncover how Surface Plasmon Resonance (SPR) can be used to gain real-time, label-free insights into PROTAC binding kinetics and ternary complex formation.

5. Optimized Stability Storage 8/23/2024

   A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.

6. Engineering CHO K1 Cells With Three Orthogonal Transposase Systems 2/2/2024

   Transposase-mediated genome engineering enables the robust and stable relocation of discrete DNA segments (transposons) in the genome, providing a valuable tool for stable transgene expression.

7. Technology Transfer Considerations 6/13/2024

   Speed and flexibility are crucial in the development of a new drug, from the laboratory to clinical trials and ultimately to the market. Explore considerations for a successful technology transfer.

8. Optimizing Performance For De-Risked Lentiviral Vector Production 6/12/2024

   Discover a de-risked, reproducible, and scalable platform for efficient GMP manufacturing of lentiviral vectors that maximizes titers and enriches recovery through upstream and downstream optimization.

9. Development Strategies For Adenovirus-Based Gene Therapies 11/11/2024

   Scaling up viral vector production can be challenging, and ensuring consistent titers and activity requires careful optimization and technical expertise.

10. Creating Equity 7/10/2025

    Eurofins PSS provided full-time, benefit-rich staffing to replace inequitable temporary roles, creating long-term value, equity, and continuity for a major biopharma client.